Exacerbation of Soft Tissue Lesions in Lead Exposed Virus Infected Mice

Biomedical and Environmental Sciences

Volumn 16, Issue 4, 2003, Pages 369-378

  Gupta, Pratibha ^a   Husain, M M ^a   Shanker, Ravi ^a   Dogra, R K S ^a   Seth, P K ^a   Maheshwari, R K ^b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Exposure; Lead acetate; Pathogenicity; SFV; Sub acute; Sub chronic

Indexed keywords

LEAD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; ORGAN WEIGHT; PATHOGENESIS; SEMLIKI FOREST ALPHAVIRUS; SOFT TISSUE DEFECT; SURVIVAL; TISSUE INJURY; VIRUS INFECTION;

ALPHAVIRUS INFECTIONS; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; LEAD; LIVER; MICE; SEMLIKI FOREST VIRUS;

ALPHAVIRUS; ANIMALIA; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 0346656469     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zelikoff, J. T., Parsons, E., and Schlesinge, R. B. (1993). Inhalation of particulate lead oxide disrupts pulmonary macrophage - mediated functions important for host defense and tumor surveillance in the lung. Environ. Res. 62, 207-222.
2. World Health Organization-Working Group (1995). Environmental Health Criteria 165, 1-279.
3. Toxicological Profile for Lead (Update) (1999). U.S. Department of Health and Human Services. Public Health Service. Agency for Toxic Substances and Disease Registry, pp. 1-587.
4. Cook, J.A., Hoffmann, E.O. and Luzio, N.R. (1975). Influence of lead and Cadmium on the susceptibility of rats. Proc. Soc. Exp. Boil. Med. 150, 741-747.
5. Sachs, H. K. (1978). Intercurrent infection in lead poisoning. Am. J. Dis. Child. 132, 315-316.
6. 3 and salivary IgA levels in lead workers. Environ. Res. 29, 351-357.
7. Descotes, J. (1986). Immunotoxicology, health aspects and regulatory issues. Trends in Pharmacol. Sci. 7, 1-3.
8. Kimber, I. (1990). Immunotoxicology of lead. In Immunotoxicity of metals and immunotoxicology. (A.D. Dayan et al., Eds.), pp 215-222, Plenum Press. New York.
9. Horiguchi, S., Endo, G., Kiyota, I., Termoto, K., Shinagawa, K., Wakitani, F., Tanaka, H., Konishi, Y., Kiyota, A., Ota, A. and Fukui, M. (1992). Frequency of cold infections in workers at a lead refinery. Osaka City Med. J. 38, 79-81.
10. Burns, L. A., Meade, B. J., and Munson, A. E. (1996). Toxic responses of the immune system. In Casarett and Doull's Toxicology, the Basic Science of Poisons. (Klassen CD, Amdur MO, Doull J, 5th edn.), pp. 355-402. McGraw Hill Publishers, New York.
11. Seth, P., Gupta, P., Husain, M. M., Mani, H., Shanker, R., Grieder, F., Schoneboom, B. A., and MAHESHWARI, R. K. (2001). Environmental pollutants and certain therapeutic agents enhance the severity of virus infection: Role of Cytokines. In "Pharmacology and Therapeutics in the New Millenium: (S. K. GUPTA Ed.), pp. 542-550, Narosa Publishing House, New Delhi.
12. Cohen, N., Modai, D., Golik, A. Weissgarten, J., Peller, S., Katz, A., Averbukh, Z., and Shaked, V. (1989). Increased Con. An induced suppressor cell activity in humans with occupational lead exposure. Environ. Res. 48, 1-6.
13. Borella, P. and Giardino, A. (1991). Lead and Cadmium at very low doses affect in vitro immune response of human lymphocytes. Environ. Res. 55, 165-167.
14. + cells and functional impairments of lymphocytes at low level occupational exposure to lead. Clin. Immunol. Immunopathol. 66, 163-168.
15. Coscia, G.C., Discalzi, G., and Ponzetti, C. (1987). Immunological aspects of occupational lead exposure. Med. Lav. 78, 360-364.
16. Wagnerova, M., Wagner, V., Madlo, Z., Zavagal, V., Wokunova, D., Kriz, J., and Mohyla, O. (1986). Seasonal variations in the level of immunoglobulins and serum proteins of children differing by exposure to air - borne lead. J. Hyg. Epidemiol. Microbiol. Immunol. 30, 127-131.
17. Guillard, Q. and Lauwerys, R. (1989). In vitro and in vivo effect of mercury, lead and cadmium on the generation of chemiluminescence by human whole blood. Biochem. Pharmacol. 38, 2819-2823.
18. Bergeret, A., Pouget, E., Tedoner, R., Meygret, T., Cadot, R., and Descotes, J. (1990). Neutrophil functions in lead exposed workers. Hum. Exp. Toxicol. 9, 231-233.
19. Queiroz, M.L.S., Almeida, M., Gallao, M. I., and Hoehr, M. F. (1993). Defective neutrophil function in workers occupationally exposed to lead. Pharmacol. Toxicol. 72, 73-77.
20. Undeger, U., Basaran, N., Canpinar, H., and Kansu, E. (1996). Immune alterations in lead exposed workers. Toxicology 109, 167-172.
21. Sata, F., Araki, S., Tanigawa, T., Morita, Y., Sakurai, S., and Katsuno, N. (1997). Changes in natural killer cell subpopulations in lead workers. Intl. Arch. Occup. Environ. Health. 69, 306-310.
22. Sata, F., Araki, S., Tanigawa, T., Sakurai, S. Natata, N., and Katsuno, N. (1998). Changes in T-Cell subpopulations in lead workers. Environ. Res. 79, 61-64.
23. Reed, L.J. and Muench, H. (1938). A simple method of estimating 50 percent end points. Amer. J. Hyg. 27, 493-497.
24. Berman, E. (1980). Toxic Metals and Their Analysis, pp. 29-53. London : Hyden.
25. 109Cd in mice during viral infection. Toxicology 71, 193-202.
26. Krzystyniak, K., Tryphonas, H., and Fournier, M. (1995). Approaches to the evaluation of chemical induced immunotoxicity. Env. Health. Perspect. 103, 17-22.
27. Heo, Y., Parsons, P.J., and Lawrence, D.A. (1996). Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol. 138, 149-157.
28. Perkin, J. and Cohen, B. (2001). An overview of the immune system. Lancet 357, 1777-1789.
29. Gainer, J.H. (1973). Activation of Rauscher leukaemia virus by metals. J. Natl. Cancer Inst. 51, 609-613.
30. Gainer, J.H. (1974). Lead aggravates viral disease and represses the antiviral activity of interferon inducers. Environ. Health Perspect 7, 113-119.
31. Thind, I.S. and Singh, N.P. (1997). Potentiation of Langat virus infection by lead intoxication - Influence on host defenses. Acta Virol. 21, 317-325.
32. Thind, I. S. and Khan, M.Y. (1978). Potentiation of the neurovirulence of Langat virus infection by lead intoxication in mice. Exp. Mol. Pathol. 29, 342-347.
33. Blakley, B.R., Archer, D.L., and Osborne, L. (1982). The effect of lead on immune and viral interferon production. Can. J. Comp. Med. 46, 43-46.
34. Koller, L.D. (1990). The immunotoxic effects of lead in lead - exposed laboratory animals. Ann. N. Y. Acad. Sci. 587, 160-167.
35. Castellino, P., Bologna, L., and Castellino, N. (1995). Lead and the kidney. In "Inorganic Lead Exposure: Metabolsim and Intoxication. (Castellino, N, Castellino, P, Sannolo, N. Eds), pp. 339, Lewis Publishers, London.
36. McCABE, M.J.Jr. (1994). Mechanisms and consequences of immunomodulation by lead, In Immunotoxicology and Immunopharmacology, (Dean J.H., Luster M.I., Munson A.E., Kimber I. Eds, 2nd edn), pp. 143-162, Raven Press, New York.
37. Grauer, E., Bennathan, D., Lustig, S., Kobiler, D., Kapon, J., and Danenberg, H. D. (2001). Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors. Life Sciences 68, 985-990.